IQVIA MIDAS Patient redefines pharma strategy by quantifying drug-treated patients across 95 countries, 1.6M+ products, 600 diseases, and 35 tumor types. It integrates value, volume, dosing, treatment duration, and compliance into a harmonized dataset, enabling transparent, patient-driven insights. Users can uncover opportunities, align portfolios with patient needs, and navigate complex markets with precision. Applications span C-Suite strategy, sales targeting, R&D pipeline planning, brand management, and market access. By linking patient dynamics with disease metrics, MIDAS Patient drives data-informed decisions that enhance growth, optimize positioning, and improve outcomes.

Join for free to read